T cells in mouse models of gut inflammation

Chemical Immunology

Volumn 71, Issue , 1998, Pages 118-138

  Simpson, Stephen J ^a   De Jong, Ype P ^a   Comiskey, Martina ^a   Terhorst, Cox ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA;

BONE MARROW CELL; CELLULAR IMMUNITY; COLITIS; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTESTINE LYMPHATIC TISSUE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0031783769     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058722     Document Type: Review

References (82)

1. Lowes JR, Jewel DP: The immunology of inflammatory bowel disease. Springer Semin Immunopathol 1990;12:251-268.
2. Podolsky DK: Inflammatory bowel disease. N Engl J Med 1991;325:928-937.
3. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstien RJ: On the etiology of Crohn's disease. Proc Natl Acad Sci USA 1996;93:9816-9820.
4. Targan SR, Murphy LK: Clarifying the causes of Crohn's. Nature Med 1995;1:1241-1243.
5. MacDonald TT: Gastrointestinal inflammation: Inflammatory bowel disease in knockout mice. Curr Biol 1994;4:261-263.
6. Sartor RB: Animal models of intestinal inflammation: in McDermott RP, Stenson WF (eds): Inflammatory Bowel Disease. New York, Elsevier, 1992, pp 337-353.
7. Sartor RB: Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis. Inflam Bowel Dis 1995;1:64-75.
8. Simpson SJ, Hollander GA, Mizoguchi E, Bhan AK, Wang B, Terhorst C: Defects in T-cell regulation: Lessons for inflammatory bowel disease; in Kagnoff MF, Kiyono H (eds): Essentials of Mucosal Immunology. San Diego, Academic Press, 1996, pp 291-304.
9. Elson CO, Sartor RB, Tennyson GS, Riddel RH: Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-1367.
10. Bhan AK, Mizoguchi E, Mizoguchi A: New models for chronic intestinal inflammation. Curr Opin Gastroenterol 1994;10:633-638.
11. Herminston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-1207.
12. Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-265.
13. Brandwein S, McCabe RP, Dadrat A: Immunologic reactivity of colitic C3H/HeJ Bir mice to enteric bacteria. Gastroenterology 1994;106:A656.
14. McCabe RP, Mills T, Ridwan B: Immune reactivity of C3H/HeJ mice with spontaneous colitis. Gastroenterology 1993;104:A656.
15. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168-4178.
16. Birkenmeir EH, Sundberg JP, Elson CO: A heritable form of colitis in mice. Gastroenterology 1992; 102:A596.
17. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin MY, Allen R, Sidman C, Proetzel G, Calvin D, Annuziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
18. Diebold R, Eis MJ, Yin MI, Biovin GP, Darrow BJ, Saffitz JY, Doetschman T: Early onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 1995;92:12215-12219.
19. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261.
20. Kuhn R, Lohler J, Rennick D, Rajewski K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
21. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-282.
22. Mizoguchi A, Mizoguchi E, Chiba C, Spiekerman GM, Tonegawa S, Nagler-Anderson C, Bhan AK: Cytokine inbalance and autoantibody production in T cell receptor α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
23. Wang B, Biron C, She J, Higgins K, Sunshine MJ, Lacy E, Lonberg N, Terhorst C: A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3ε gene. Proc Natl Acad Sci USA 1994;91:9402-9406.
24. Hollander GA, Wang B, Nichogiannopoulou A, Platenberg P-P, Van Ewijk W, Burakofl SJ, Gutierrez-Ramos JC, Terhorst C: A developmental control point in the induction of thymic cortex regulated by a subpopulation of pro-thymocytes. Nature 1995;373:350-353.
25. Wang B, Levelt C, Salio M, Zheng D, Sancho J, Liu C-P, Huang M, Higgins K, Sunshine M-J, Eichman K, Lacy E, Lonberg N, Terhorst C: Abrogation of early T cell development by excessive signal transduction through CD3ε. Int Immunol 1995;7:435-448.
26. Hollander GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B: Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27-38.
27. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993; 178:237-244.
28. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL: Phenotypically distinct subsets of CD4+ T cells induce of protect from chronic intestinal inflammation in C.B-17 scid mice. Int Immunol 1993;5:1461-147 .
29. high CD4+ T cells. Immunity 1994;1: 553-562.
30. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
31. Powrie F: T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity 1995; 3:171-174.
32. lo CD4+ T cells. J Exp Med 1996;183: 2669-2674.
33. Simpson SJ, Hollander GA, Mizoguchi E, Allen D, Wang B, Bhan AK, Terhorst C: Expression of pro-inflammatory cytokines by TCRαβ+ and TCRγδ+ T cells in and experimental model of colitis. Eur J Immunol 1997;27:17-25.
34. Shah SA, Simpson SJ, Brown LF, Comiskey M, de Yong YP, Allen D, Terhorst C: Development of colonic adenocarcinoma in a mouse model of ulcerative colitis. Inflam Bowel Dis 1997;in press.
35. Abbas A, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383: 787-793.
36. Mossman TR, Coffman RL: Th-1 and Th-2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-173.
37. Coffman R, von der Weid T: Multiple pathways for the initiation of T helper (Th2) responses. J Exp Med 1997;185:373-375.
38. Strober W, Ehrhardt RO: Chronic intestinal inflammation: An unexpected outcome in cytokine and T cell mutant mice. Cell 1993;75:203-205.
39. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach M, Rennick D: Enterocolitis and colon cancer in interleukin 10-deficient mice are associated with aberrant cytokine production and CD4+ Th-1 like responses. J Clin Invest 1996;98:1010-1020.
40. Schmitt E, Hoeh P, Huels C, Goedert S, Palm N, Rude E, Germann T: T helper 1 development of naive CD4+ T cells requires the coordinate action of interleukin 12 and interferon gamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994;24:793-798.
41. Groux H, O'Garra A, Bigler M, Rouleau M, Antoneko S, Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen specific T cell responses and prevents colitis. Nature 1997;389:737-742.
42. Weiner HL, Inobe J, Kuchroo V, Chen Y: Induction and characterisation of TGFβ secreting cells. FASEB 1996;10:A1444.
43. Saoudi A, Seddon B, Fowell D, Mason D: The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med 1996;184:2393-2398.
44. Saoudi A, Seddon B, Fowell D, Mason D: The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 1996;149:195-216.
45. Horwitz DA, Gray DJ, Ohtsuka K, Hirowkawa M, Takahashi T: The immunoregulatory effects of NK cells: The role for TGF-β and implications for autoimmunity. Immunol Today 1997;18:538-542.
46. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific immunity. Ann Rev Immunol 1995;13:251-276.
47. Hall SS: IL-12 at the crossroads. Science 1995;268:1432-1434.
48. Gerosa F, Paganin C, Peritt D, Pailoa F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G: Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 1996;183:2559-2569.
49. Gollob JA, Kawasaki H, Ritz J: Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur J Immunol 1997;27:647-652.
50. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996;26:659-668.
51. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH: Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 1994;24:2271-2278.
52. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-5079.
53. Maruo S, Toyo-oka K, Oh-hora M, Tai XG, Iwata H, Takenaka H, Yamada S, Ono S, Hamaoka T, Kobayashi M, Wysocka M, Trinchieri G, Fujiwara H: IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. J Immunol 1996;156:1748-1755.
54. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-1290.
55. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM: Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995;181:1755-1762.
56. Ihle JN: STATs: Signal transducers and activators of transcription. Cell 1996;84:331-334.
57. Kaplan MH, Sun YL, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996;382:174-177.
58. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doberty PC: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-174.
59. Bacon CM, Petricoin EF, Ortaldo JR, Rees RC, Larner AC, Johnston JA, O'Shea JJ: Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 1995;92:7307-7311.
60. Magram J, Connaughton SE, Warner RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996;4:471-481.
61. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F: Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-1178.
62. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F: Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-832.
63. Plevey SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR: A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-6282.
64. Niessner M, Volk BA: Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammamtory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-435.
65. Murata Y, Ishiguro Y, Itoh J, Munakata A, Yoshida Y: The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995;30(suppl 8): 56-60.
66. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
67. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M: Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996;26: 1647-1651.
68. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-1550.
69. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Kastelein R, Bazan F, O'Garra A: IGIF does not drive Th-1 development but synergises with IL-12 for interferon γ production and activates IRAK and NF kB. Immunity 1997;7:571-581.
70. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-1742.
71. van Dulleman HM: Complete remissions of steroid-refractory Crohn's disease after administration of monoclonal anti-TNF antibody cA2. Gastroenterology 1994;106:A1054.
72. van Dulleman HJM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J: Treatment of Crohn's disease with anti-tumour necrosis factor chimeric monoclonal antibody (CA2). Gastroenterology 1995;109:129.
73. Orange J, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA: Mechanisms of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J Exp Med 1995;181:901-914.
74. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL: Lymphotoxin but not tumour necrosis factor functions to maintain splenic architecture: An humoral responsiveness in adult mice. Eur J Immunol 1997;in press.
75. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA: Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta deficient mice. Immunity 1996;6:491-500.
76. Ware CF, VanArsdale TL, Crowe PD, Browning JL: The ligands and receptors of the lymphotoxin system; in Griffiths GM, Tschopp J (eds): Pathways for Cytolysis. Berlin, Springer, 1995, pp 175-217.
77. Berke G: The CTL's kiss of death. Immunol Today 1995;81:9-12.
78. Nagata S, Goldstein P: The Fas death factor. Science 1995;267:1449-1456.
79. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer P, Moller P: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis. Gastroenterology 1997;113:160-167.
80. Ma A: Fas and the underprivileged intestine. Gastroenterology 1997;113:345-348.
81. Bonhagen K, Thoma S, Bland P, Bregenholt S, Rudolphi A, Claesson MH: Cytotoxic reactivity of gut lamina propria CD4+ αβ T cells in SCID mice with colitis. Eur J Immunol 1996;26:3074-3083.
82. Simpson SJ, Mizoguchi E, Allen D, Bhan AK, Terhorst C: Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-2625.